Scientists at Manus Neurodynamica, an Edinburgh-based medical technology company, developed a pen that provides an early diagnosis of Alzheimer’s disease. The Neuromotor Pen works by measuring limb and hand motion while a patient writes. It logs this data and, using artificial intelligence, compares it to motor patterns from those with impairments. While the pen is presently in its trial phase (with only one more to go), scientists are hopeful this breakthrough can give people more peace of mind about any tremors or abnormalities they make experience. Manus Neurodynamica also developed a similar device to diagnose Parkinson’s.

Source: The Times April 25, 2022 16:28 UTC